SUMMARY

Thymic function can become severely compromised with HIV infection. The virus directly infects a variety of thymocyte subsets, including DP cells, SP CD4 cells, and thymic stromal cells, resulting in thymocyte depletion and suppression of thymic output.

references

1. Schmitt, N., Chene, L., Boutolleau, D., Nugeyre, M.T., Guillemard, E., Versmisse, P., Jacquemot, C,, Barre-Sinoussi, F., and Israel, N., Positive regulation of CXCR4 expression and signaling by inter­leukin-7 in CD4⁺ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication, J. Virol., 77(10), 5784, 2003.

2. Brooks, D.G., Kitchen, S.G., Kitchen, C.M., Scripture-Adams, D.D., and Zack, J.A., Generation of HIV latency during thymopoiesis, Nat. Med., 7(4), 459, 2001.

3. Shen, A., Zink, M.C., Mankowski, J.L., Chadwick, K., Margolick, J.B., Carruth, L.M., Li, M., Clements, J.E., and Siliciano, R.F., Resting CD4⁺ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-macaca nemestrina model of human immunode­ficiency virus type 1-infected patients on highly active antiretroviral therapy, J.

4. Berkowitz, R.D., Alexander, S., and McCune, J.M., Causal relationships between HIV-1 coreceptor utilization, tropism, and pathogenesis in human thymus, AIDS Res. Hum. Retroviruses, 16(11), 1039,

2000.

5. Berkowitz, R.D., Beckerman, K.P., Schall, T.J., and McCune, J.M., CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation, J. Immunol., 161(7), 3702, 1998.

6. Taylor J.R., Kimbrell, K.C., Scoggins, R., Delaney, M., Wu, L., and Camerini, D., Expression and function of chemokine receptors on human thymocytes: implication for infection by human immun­odeficiency virus type 1, J. Virol., 75(18), 8752, 2001.

7. Schnittman, S.M., Denning, S.M., Greenhouse, J.J., Justement, J.S., Baseler, M., Kurtzberg, J., Haynes, B.F., and Fauci, A.S., Evidence for susceptibility of intrathymic T-cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCR⁺ and TCR⁺ to human immunodeficiency virus infection: a mechanism for CD4⁺ (T4) lymphocyte depletion, Proc. Natl. Acad. Sci. U.S.A., 87(19), 7727, 1990.

8. Chene, L., Nugeyre, M.T., Guillemard, E., Moulian, N., Barre-Sinoussi, F., and Israel, N.,Thymocyte- thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4⁺ CD8^- CD3⁺ thymocytes: a critical role for tumor necrosis factor and interleukin-7, J. Virol., 73(9), 7533, 1999.

9. Kitchen, S.G., and Zack, J.A., CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus, J. Virol., 71(9), 6928, 1997.

10. Jamieson, B.D., and Zack, J.A., In vivo pathogenesis of a human immunodeficiency virus type 1 reporter virus, J. Virol., 72(8), 6520, 1998.

11. Lee, S., Goldstein, H., Baseler, M., Adelsberger J., and Golding, H., Human immunodeficiency virus type 1 infection of mature CD3^hiCD8⁺ thymocytes, J.

12. Gurney, K.B., Yang, O.O., Wilson, S.B., and Uittenbogaart, C.H., TCR⁺ and CD161⁺ thymocytes express HIV-1 in the SCID-hu mouse, potentially contributing to immune dysfunction in HIV infec­tion, J. Immunol., 169(9), 5338, 2002.

13. Sandborg, C.I., Imfeld, K.L., Zaldivar, F., jr., and Berman, M.A., HIV type 1 induction of interleukin 1 and 6 production by human thymic cells, AIDS Res. Hum. Retroviruses, 10(10), 1221, 1994.

14. Beaulieu, S., Kessous, A., Landry, D., Montplaisir, S., Bergeron, D., and Cohen, E.A., In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type 1, Virology, 222(1), 214, 1996.

15. Cameron P.U., Lowe, M.G., Sotzik, F., Coughlan, A.F., Crowe, S.M., and Shortman, K., The interaction of macrophage and non-macrophage tropic isolates of HIV-1 with thymic and tonsillar dendritic cells in vitro, J. Exp. Med., 183(4), 1851, 1996.

16. Kourtis A.P., Ibegbu, C.C., Scinicarrielo, F., and Lee, F.K., Effects of different HIV strains on thymic epithelial cultures, Pathobiology, 69(6), 329, 2001.

17. Schnittman, S.M., Singer, K.H., Greenhouse, J.J., Stanley, S.K., Whichard, L.P., Le, P.T., Haynes, B.F., and Fauci, A.S., Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells, J. Immunol., 147(8), 2553, 1991.

18. Burke, A.P., Anderson, D., Benson, W., Turnicky, R., Mannan, P., Liang, Y.H., Smialek, J., and Virmani, R., Localization of human immunodeficiency virus 1 RNA in thymic tissues from asymptomatic drug addicts, Arch. Pathol. Lab. Med., 119(1), 36, 1995.

19. Haynes B.F., Markert, M.L., Sempowski, G.D., Patel, D.D., and Hale, L.P., The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection, Annu. Rev. Immunol., 18, 529, 2000.

20. Rosenzweig, M., Clark, D.P., and Gaulton, G.N., Selective thymocyte depletion in neonatal HIV-1 thymic infection, AIDS, 7(12), 1601, 1993.

21. Autran, B., Guiet P., Raphael, M., Grandadam, M., Agut, H., Candotti, D., Grenot, P., Peuch, F., Debre, P., and Cesbron, J.Y., Thymocyte and thymic microenvironment alterations during a systemic HIV infection in a severe combined immunodeficient mouse model, AIDS, 10(7), 717, 1996.

22. Jamieson, B.D., Douek, D.C., Killian, S., Hultin, L.E., Scripture-Adams, D.D., Giorgi, J.V., Marelli D., Doup, R.A., and Zack, J.A., Generation of functional thymocytes in the human adult, Immunity, 10(5), 569, 1999.

23. Kourtis, A.P., Ibegbu, C., Nahmias, A.J., Lee, F.K., Clark, W.S., Sawyer, M.K., and Nesheim, S., Early progression of disease in HIV-infected infants with thymus dysfunction, New Engl. J. Med., 335(19), 1431, 1996.

24. Petrie, H.T., Cell migration and the control of post-natal T-cell lymphopoiesis in the thymus, Nat. Rev. Immunol., 3, 859, 2003.

25. Scadden, D.T., Shen, H., and Cheng, T., Hematopoietic stem cells in HIV disease, J. Natl. Cancer Inst. Monogr., 28, 24, 2000.

26. Scadden, D.T., Stem cells and immune reconstitution in AIDS, Blood Rev., 17, 227, 2003.

27. Knutsen, A.P., Roodman, S.T., Freeman, J.J., Mueller, K.R., and Bouhasin, J.D., Inhibition of thy- mopoiesis of CD34⁺ cell maturation by HIV-1 in an in vitro CD34⁺ cell and thymic epithelial organ culture model, Stem Cells, 17(6), 327, 1999.

28. Jenkins, M., Hanley, M.B., Moreno, M.B., Wieder, E., and McCune, J.M., Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo, Blood, 91(8), 2672, 1998.

29. McCune, J.M. and Kaneshima, H., The hematopathology of HIV-1 disease: experimental analysis in vivo, in Human Hematopoiesis in SCID Mice, Roncarolo, M.G., Namikawa, R., and Pault, B., Eds., R. G. Landes Co., Austin, TX, 1995.

30. Stanley, S.K., Kessler, S.W., Justement, J.S., Schnittman, S.M., Greenhouse, J.J., Brown, C.C., Muso- ngela, L., Musey, K., Kapita, B., and Fauci, A.S., CD34⁺ bone marrow cells are infected with HIV in a subset of seropositive individuals, J.

31. Chelucci, C., Hassan, H.J., Locardi, C., Bulgarini, D., Pelosi, E., Mariani, G., Testa, U., Federico, M., Valtieri, M., and Peschle, C., In vitro human immunodeficiency virus-1 infection of purified hematopoietic progenitors in single-cell culture, Blood, 85(5), 1181, 1995.

32. Davis B.R., Schwartz, D.H., Marx, J.C., Johnson, C.E., Berry, J.M., Lyding J., Merigan, T.C., and Zander, A., Absent or rare human immunodeficiency virus infection of bone marrow stem/ progenitor cells in vivo, J. Virol., 65(4), 1985, 1991.

33. Neal, T.F., Holland, H.K., Baum, C.M., Villinger, F., Ansari, A.A., Saral, R., Wingard, J.R., and Fleming, W.H., CD34⁺ progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1, Blood, 86(5), 1749, 1995.

34. Moses, A., Nelson, J., and Bagby, G.C., The influence of human immunodeficiency virus-1 on hematopoiesis, Blood, 91(5), 1479, 1998.

35. Yurasov, S.V., Pettoello-Mantovani, M., Raker, C.A., and Goldstein, H., HIV type 1 infection of human fetal bone marrow cells induces apoptotic changes in hematopoietic precursor cells and suppresses their in vitro differentiation and capacity to engraft SCID mice, AIDS Res. Hum. Retroviruses, 15(18), 1639, 1999.

36. Calenda, V., Graber, P., Delamarter, J.F., and Chermann, J.C., Involvement of HIV Nef protein in abnormal hematopoiesis in AIDS: in vitro study on bone marrow progenitor cells, Eur. J. Haematol., 52(2), 103, 1994.

37. Maciejewski, J.P., Weichold, F.F., and Young, N.S., HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoprotein and TNF-, J. Immunol., 153(9), 4303, 1994.

38. Koka, P.S., Jamieson, B.D., Brooks, D.G., Zack, J.A., Human immunodeficiency virus type 1-induced hematopoietic inhibition is independent of productive infection of progenitor cells in vivo, J. Virol., 73(11), 9089, 1999.

39. Koka, P.S., Fraser, J.K., Bryson, Y., Bristol, G.C., Aldrovandi, G.M., Daar, E.S., and Zack, J.A., Human immunodeficiency virus inhibits multilineage hematopoiesis in vivo, J.

40. Geissler, R.G., Ganser, A., Ottmann, O.G., Gute, P., Morawetz, A., Guba, P., Helm, E.B., and Hoelzer, D., In vitro improvement of bone marrow-derived hematopoietic colony formation in HIV-positive patients by -D-tocopherol and erythropoietin, Eur. J. Haematol., 53(4), 201, 1994.

41. Geissler, R.G., Rossol, R., Mentzel, U., Ottmann, O.G., Klein, A.S., Gute, P., Helm, E.B., Hoelzer, D., and Ganser A., -T cell-receptor-positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients, AIDS Res. Hum. Retroviruses, 12(7), 577, 1996.

42. Moses, A.V., Williams, S., Heneveld, M.L., Strussenberg, J., Rarick, M., Loveless, M., Bagby, G., and Nelson, J.A., Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors, Blood, 87(3), 919, 1996.

43. Gill, V., Shattock, R.J., Scopes, J., Hayes, P., Freedman, A.R., Griffin, G.E., Gordon-Smith, E.C., Gibson, and F.M., Human immunodeficiency virus infection impairs hemopoiesis in long-term bone marrow cultures: nonreversal by nucleoside analogues, J. Infect. Dis., 176(6), 1510, 1997.

44. Dobrescu, D., Ursea, B., Pope, M., Asch, A.S., and Posnett, D.N., Enhanced HIV-1 replication in V 12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpesvirus superan­tigen, Cell, 82, 753, 1995.

45. Komanduri, K.V., Salha, M.D., Sekaly, R.P., and McCune, J.M., Superantigen-mediated deletion of specific T cell receptor Vβ subsets in the SCID-hu Thy/Liv mouse is induced by staphylococcal enterotoxin B, but not HIV-1, J. Immunol., 158, 544, 1997.

46. Boldt-Houle, D.M., Jamieson, B.D., Aldrovandi, G.M., Rinaldo, C.R., Jr., Ehrlich, G.D., and Zack,

J.A., Loss of T cell receptor V repertoires in HIV type 1-infected SCID-hu mice, AIDS Res. Hum. Retroviruses, 13(2), 125, 1997.

47. Bouhdoud, L., Villain, P., Merzouki, A., Arella, M., and Couture, C., T-cell receptor-mediated anergy of a human immunodeficiency virus (HIV) gp120-specific CD4⁺ cytotoxic T-cell clone, induced by a natural HIV type 1 variant peptide, J. Virol., 74(5), 2121, 2000.

48. Fackler, O.T. and Baur, A.S., Live and let die: Nef functions beyond HIV replication, Immunity, 16(4), 493, 2002.

49. Kremer, K.N., Humphreys, T.D., Kumar, A., Qian, N.X., and Hedin, K.E., Distinct role of ZAP-70 and Src homology 2 domain-containing leukocyte protein of 76 kDa in the prolonged activation of extracellular signal-regulated protein kinase by the stromal cell-derived factor-1/CXCL12 chemokine, J. Immunol., 171(1), 360, 2003.

50. Bouillet, P., Purton, J.F., Godfrey, D.I., Zhang, L.C., Coultas, L., Puthalakath, H., Pellegrini, M., Cory, S., Adams, J.M., and Strasser, A., BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes, Nature, 415, 922, 2002.

51. Rathmell, J.C., Lindsten, T., Zong, W.X., Cinalli, R.M., and Thompson, C.B., Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis, Nat. Immunol., 3(10), 932, 2002.

52. Gougeon, M.L., Apoptosis as an HIV strategy to escape immune attack, Nat. Rev. Immunol., 3, 392, 2003.

53. Page, D.M., Roberts, E.M., Peschon, J.J., and Hedrick, S.M., TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection, J. Immunol., 160, 120, 1998.

54. Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N., and Nagata, S., Enhanced and accelerated lymphoproliferation in Fas-null mice, Proc. Natl. Acad. Sci. U.S.A., 93, 2131, 1996.

55. Cretney, E., Uldrich, A.P., Berzins, S.P., Strasser, A., Godfrey, D.I., and Smyth, M.J., Normal thy­mocyte negative selection in TRAIL-deficient mice, J. Exp. Med., 198(3), 491, 2003.

56. Zhang, J., Cado, D., Chen, A., Kabra, N.H., and Winoto, A., Fas-mediated apoptosis and activation- induced T-cell proliferation are defective in mice lacking FADD/Mort1, Nature, 392, 296, 1998.

57. Marsden V.S., O'Connor, L., O'Reilly, L.A., Stilke, J., Metcalf, D., Ekert, P.G., Huang, D.C., Cecconi, F., Kuida, K., Tomaselli, K.J., Roy, S., Nicholson, D.W., Vaux, D.L., Bouillet, P., Adams, J.M., and Strasser, A., Apoptosis initiated by Bcl-2-regulated caspase activation indepen­dently of the cytochrome c/Apaf-1/caspase-9 apoptosome, Nature, 419, 634, 2002.

58. Hara, H., Takeda, A., Takeuchi, M., Wakeham, A.C., Itie, A., Sasaki, M., Mak T.W., Yoshimura, A., Nomoto, K., and Yoshida, H. The apoptotic protease-activating factor 1-mediated pathway of apoptosis is dispensable for negative selection of thymocytes, J. Immunol., 168, 2288, 2002.

59. Rosenzweig, M., Connole, M., Forand-Barabasz, A., Tremblay, M.P., Johnson, R.P., and Lackner, A.A., Mechanisms associated with thymocyte apoptosis induced by simian immunodeficiency virus, J. Immunol., 165(6), 3461, 2000.

60. Tinkle, B.T., Ueda, H., Ngo, L., Luciw, P.A., Shaw, K., Rosen, C.A., and Jay, G., Transgenic dissection of HIV genes involved in lymphoid depletion, J. Clin. Invest., 100(1), 32, 1997.

61. Lindemann, D., Wilhelm R., Renard, P., Althage, A., Zinkernagel, R., and Mous, J., Severe immun­odeficiency associated with a human immunodeficiency virus 1 NEF/3-long terminal repeat transgene, J. Exp. Med., 179(3), 797, 1994.

62. Hanna, Z., Kay, D.G., Rebai, N., Guimond, A., Jothy, S., and Jolicoeur, P., Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice, Cell, 95(2), 163, 1998.

63. Brady, H.J., Pennington, D.J., Miles, C.G., and Dzierzak, E.A., CD4 cell surface downregulation in HIV-1 Nef transgenic mice is a consequence of intracellular sequestration, EMBO J., 12(13), 4923, 1993.

64. Skowronski, J., Parks, D., and Mariani, R., Altered T cell activation and development in transgenic mice expressing the HIV-1 Nef gene, EMBO J., 12(2), 703, 1993.

65. Stoddart, C.A., Geleziunas, R., Ferrell, S., Linquist-Stepps, V., Moreno, M.E., Bare, C., Xu, W., Yonemoto, W., Bresnahan, P.A., McCune, J.M., and Greene, W.C., Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis, J. Virol., 77(3), 2124, 2003.

66. Duus, K.M., Miller, E.D., Smith, J.A., Kovaley, G.I., and Su, L., Separation of human immunodefi­ciency virus type-1 replication from Nef-mediated pathogenesis in the human thymus, J. Virol., 75(8), 3916, 2001.

67. Jamieson, B.D., Aldrovandi, G.M., Planelles, V., Jowett, J.B., Gao, L., Bloch, L.M., Chen, I.S., and Zack, J.A., Requirement of human immunodeficiency virus type 1 Nef for in vivo replication and pathogenicity, J. Virol., 68(6), 3478, 1994.

68. Stove, V., Naessens, E., Stove, C., Swigut, T., Plum, J., and Verhasselt, B., Signaling but not trafficking function of HIV-1 protein Nef is essential for Nef-induced defects in human intrathymic T-cell development, Blood, 102(8), 2925, 2003.

69. Verhasselt, B., Naessens, E., Verhofstede, C., De Smedt, M., Schollen, S., Kerre, T., Vanhecke, D., and Plum, J., Human immunodeficiency virus Nef gene expression affects generation and function of human T cells, but not dendritic cells, Blood, 94(8), 2809, 1999.

70. Maroder, M., Scarpa, S., Screpanti, I., Stigliano, A., Meco, D., Vacca, A., Stuppia, L., Frati, L., Modesti, A., and Gulino, A., Human immunodeficiency virus type 1 Tat protein modulates fibronectin expression in thymic epithelial cells and impairs in vitro thymocyte development, Cell Immunol., 168(1), 49, 1996.

71. Brady, H.J., Abraham, D.J., Pennington, D.J., Miles, C.G., Jenkins, S., and Dzierzak, E.A., Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice, J. Virol., 69(12), 7622, 1995.

72. Wang, B., Biron, C., She, J., Higgins, K., Sunshine, M., Lacy, E., Lonberg, N., and Terhorst, C., A block in both early T lymphocyte and natural killer cell development in transgenic mice with high- copy numbers of the human CD3E gene, Proc. Natl. Acad. Sci. U.S.A., 91, 9402, 1994.

73. Braun, J., Valentin, H., Nugeyre, M-T, Ohayon, H., Gounon, P., and Barre-Sinoussi, F., Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1, Virology, 225(2), 413, 1996.

74. Chene, L., Nugeyre, M.T., Guillemard, E., Moulian, N., Barre-Sinoussi, F., and Israel, N., Thy­mocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and IL-7, J. Virol., 73(9), 7533, 1999.

75. Chene, L., Nugeyre, M.T., Barre-Sinoussi, F., and Israel, N., High-level replication of human immu­nodeficiency virus in thymocytes requires NF-B activation through interaction with thymic epithelial cells, J. Virol. 73(3), 2064, 1999.

76. Rothe, M., Chene, L., Nugeyre, M.T., Braun, J., Barre-Sinoussi, F., and Israel, N., Contact with thymic epithelial cells as a prerequisite for cytokine-enhanced human immunodeficiency virus type 1 repli­cation in thymocytes, J. Virol., 72(7), 5852, 1998.

77. Uittenbogaart, C.H., Anisman, D.J., Zack, J.A., Economides, A., Schmid, I., and Hays, E.F., Effects of cytokines on HIV-1 production by thymocytes, Thymus, 23(3-4), 155, 1994-1995.

78. Pedroza-Martins, L., Boscardin, W.J., Anisman-Posner, D.J., Schols, D., Bryson, Y.J., and Uitten- bogaart, C.H., Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants, J. Virol., 76(14), 6929, 2002.

79. Nielsen, S.D., Jeppesen, D.L., Kolte, L., Clark, D.R., Sorensen, T.U., Dreves, A.M., Ersboll, A.K., Ryder, L.P., Valerius, N.H., and Nielsen, J.O., Impaired progenitor cell function in HIV-negative infants of HIV-positive mothers results in decreased thymic output and low CD4 counts, Blood, 98(2), 398,

2001.

80. Su, L., Kaneshima, H., Bonyhadi, M., Salimi, S., Kraft, D., Rabin, L., and McCune, J.J., HIV-1- induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo, Immunity, 2(1), 25, 1995.

81. Beaulieu, S., Lafontaine, M., Richer, M., Courchesne, I., Cohen, E.A., and Bergeron, D., Character­ization of the cytotoxic factor(s) released from thymic dendritic cells upon human immunodeficiency virus type 1 infection, Virology, 241(2), 285, 1998.

82. Keir, M.E., Stoddart, C.A., Linquist-Stepps, V., Moreno, M.E., and McCune, J.M., IFN- secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1- infected thymus, J. Immunol., 168(1), 325, 2002.

83. Keir, M.E., Rosenberg, M.G., Sandberg, J.K., Jordan, K.A., Wiznia, A., Nixon, D.F., Stoddart, C.A., and McCune, J.M., Generation of CD3⁺CD8^low thymocytes in the HIV type 1-infected thymus, J. Immunol., 169(5), 2788, 2002.

84. Kovalev, G., Duus, K., Wang, L., Lee, R., Bonyhadi, M., Ho, D., McCune, J.M., Kaneshima, H., and Su, L., Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: evidence of indirect mechanisms, J. Immunol., 162(12), 7555, 1999.

85. Koka, P.S., Brooks, D.G., Razai, A., Kitchen, C.M., and Zack, J.A., HIV type I infection alters cytokine mRNA expression in thymus, AIDS Res. Hum. Retroviruses, 19(1), 1, 2003.

86. Llano, A., Barretina, J., Gutierrez, A., Blanco, J., Cabrera, C., Clotet, B., and Este, J.A., Interleukin- 7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium­inducing variants in human immunodeficiency virus type 1-positive individuals, J. Virol., 75(21), 10319, 2001.

87. Correa, R., Resino, S., and Munoz-Fernandez, M.A., Increased interleukin-7 plasma levels are asso­ciated with recovery of CD4⁺ T cells in HIV-infected children, J. Clin. Immunol., 23(5), 401, 2003.

88. Al-Harthi, L. and Landay, A., Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategies, J. Hematother. Stem Cell Res., 11, 777, 2002.

89. Clerici, M. and Shearer, G.M., The Th1-Th2 hypothesis of HIV infection: new insights, Immunol. Today, 15, 575, 1994.

90. Altfeld, M., Addo, M.M., Kreuzer, K.A., Rockstroh, J.K., Dumoulin, F.L., Schliefer, K., Leifeld, L., Sauerbruch, T., and Spengler, U., T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions, J. Acquir. Immune Defic. Syndr., 23, 287, 2000.

91. Alonso, K., Pontiggia, P., Medenica, R., and Rizzo, S., Cytokine patterns in adults with AIDS, Immunol. Invest., 26, 341, 1997.

92. Clerici, M., Galli, M., Bosis, S., Gervasoni, C., Moroni, M., and Norbiato, G., Immunoendocrinologic abnormalities in human immunodeficiency virus infection, Ann. NYAcad. Sci., 917, 956, 2000.

93. Metcalf, D., The autonomous behaviour of normal thymus grafts, Aust. J. Exp. Biol., 41, 437, 1963.

94. Metcalf, D., Sparrow, N., Nakamura, K., and Ishidate, M., The behavior of thymus grafts in high and low leukemia strains of mice, Aust. J. Exp. Biol., 39, 441, 1961.

95. Berzins, S.P., Boyd, R.L., and Miller, J.F., A central role for thymic emigrants in peripheral T cell homeostasis, Proc. Natl. Acad. Sci. U.S.A., 96, 9787, 1999.

96. Gabor, M.J., Scollay, R., and Godfrey, D.I., Thymic T cell export is not influenced by the peripheral T cell pool, Eur. J. Immunol., 27, 2986, 1997.

97. Berzins, S.P., Boyd, R.L., and Miller, J.F., The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool, J. Exp. Med., 187, 1839, 1998.

98. Wykrzykowska, J.J., Rosenzweig, M., Veazey, R.S., Simon, M.A., Halvorsen, K., Desrosiers, R.C., Johnson, R.P., and Lackner, A.A., Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus, J. Exp. Med., 187(11), 1767, 1998.

99. Sopper, S., Nierwetberg, D., Halbach, A., Sauer, U., Scheller, C., Stahl-Hennig, C., Matz-Rensing,

K., Schafer, F., Schneider, T., ter Meulen, V., and Muller, J.G., Impact of simian immunodeficiency virus (SIV) infection on lymphocyte numbers and T-cell turnover in different organs of rhesus monkeys, Blood, 101(4), 1213, 2003.

100. Douek, D.C., Betts, M.R., Hill, B.J., Little, S.J., Lempicki, R., Metcalf, J.A., Casazza, J., Yoder, C., Adelsberger, J.W., Stevens, R.A., Baseler, M.W., Keiser, P., Richman, D.D., Davey, R.T., and Koup, R.A., Evidence for increased T cell turnover and decreased thymic output in HIV infection, J. Immunol. 167(11), 6663, 2001.

101. Sodora, D.L., Milush, J.M., Ware, F., Wozniakowski, A., Montgomery, L., McClure, H.M., Lackner, A.A., Marthas, M., Hirsch, V., Johnson, R.P., Douek, D.C., and Koup, R.A., Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alteration within the thymus, J. Virol., 76(19), 9981, 2002.

102. Correa, R. and Munoz-Fernandez, M.A., Production of new T cells by thymus in children: effect of HIV infection and antiretroviral therapy, Pediat. Res., 52(2), 207, 2002.

103. McCune, J.M., Hanley, M.B., Cesar, D., Halvorsen, R., Hoh, R., Schmidt, D., Wieder, E., Deeks, S., Siler, S., Neese, R., and Hellerstein, M., Factors influencing T-cell turnover in HIV-1-seropositive patients, J. Clin. Invest., 105(5), R1, 2000.

104. Teixeira, L., Valdez, H., McCune, J.M., Koup, R.A., Badley A.D., Hellerstein, M.K., Napolitano, L.A., Douek, D.C., Mbisa, G., Deeks, S., Harris, J.M., Barbour, J.D., Gross, B.H., Francis, I.R., Halvorsen, R., Asaad, R., and Lederman, M.M., Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function, AIDS, 15(14), 1749, 2001.

105. Ruiz-Mateos, E., de la Rosa, R., Franco, J.M., Martinez-Moya, M., Rubio, A., Soriano, N., Sanchez- Quijano, A., Lissen, E., and Leal, M., Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy, AIDS, 17(7), 947, 2003.

106. De Rossi, A., Walker, A.S., Klein, N., De Forni, D., King, D., and Gibb, D.M., Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Peadiatric European Network for Treatment of AIDS (PENTA) 5 Trial, J. Infect. Dis., 186(3), 312, 2002.

107. Ometto, L., De Forni, D., Patiri, F., Trouplin, V., Mammano, F., Giacomet, V., Giaquinto, C., Douek, D., Koup, R., and De Rossi, A., Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness, AIDS, 16(6), 839, 2002.

108. Rubio, A., Martinez-Moya, M., Leal, M., Franco, J.M., Ruiz-Mateos, E., Merchante, E., Sanchez- Quijano, A., and Lissen, E., Changes in thymus volume in adult HIV-infected patients under HAART: correlation with the T-cell repopulation, Clin. Exp. Immunol., 130(1), 121, 2002.

109. Kolte, L., Dreves, A.M., Ersboll, A.K., Strandberg, C., Jeppesen, D.L., Nielsen, J.O., Ryder, L.P., and Nielsen, S.D., Association between larger thymic size and higher thymic output in human immuno­deficiency virus-infected patients receiving highly active antiretroviral therapy, J. Infect. Dis., 185(11), 1578, 2002.

110. Phenix, B.N., Lum, J.J., Nie, Z., Sanchez-Dardon, J., and Badley, A.D., Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss, Blood, 98, 1078, 2001.

111. Phenix, B.N. and Badley, A.D., Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection, Biochimie, 84, 251, 2002.

112. Phenix, B.N., Cooper, C., Owen, C., and Badley, A.D., Modulation of apoptosis by HIV protease inhibitors, Apoptosis, 7, 295, 2002.

113. Delgado, J., Leal, M., Ruiz-Mateos, E., Martinez-Moya, M., Rubio, A., Merchante E., de la Rosa, R., Sanchez-Quijano, A., and Lissen, E., Evidence of thymic function in heavily antiretroviral-treated human immunodeficiency virus type 1-infected adults with long-term virologic treatment failure, J. Infect. Dis., 186(3), 410, 2002.

114. Lecossier, D., Bouchonnet, F., Schneider, P., Clavel, F., Hance, A.J., Centre de Recherche Integre sur le VIH Bichat-Claude Bernard, Discordant increases in CD4⁺ T cells in human immunodeficiency virus-infected patients experiencing virologic treatment failure: role of changes in thymic output and T cell death, J. Infect. Dis., 183(7), 1009, 2001.

115. Stoddart, C.A., Liegler, T.J., Mammano, F., Linquist-Stepps, V.D., Hayden, M.S., Deeks, S.G., Grant, R.M., Clavel, F., and McCune, J.M., Impaired replication of protease inhibitor-resistant HIV-1 in human thymus, Nat. Med., 7(6), 712, 2001.

116. Amado, R.G., Jamieson, B.D., Cortado, R., Cole, S.W., Zack, J.A., Reconstitution of human thymic implants is limited by human immunodeficiency virus breakthrough during antiretroviral therapy, J. Virol., 73(8), 6361, 1999.

117. De Paoli, P., Bortolin, M.T., Zanussi, S., Monzoni, A., Pratesi, C., and Giacca, M., Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2, Clin Exp. Immunol., 125(3), 440, 2001.

118. Carcelain, G., Saint-Mezard, P., Altes, H.K., Tubiana, R., Grenot, P., Rabian, C., de Boer R., Costa- gliola, D., Katlama, C., Debre, P., and Autran, B., IL-2 therapy and thymic production of naive CD4 T cells in HIV-infected patients with severe CD4 lymphopenia, AIDS, 17(6), 841, 2003.

119. Pido-Lopez, J., Burton, C., Hardy, G., Pires, A., Sullivan, A., Gazzard, B., Aspinall, R., Gotch, F., and Imami, N., Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune), AIDS Res. Hum. Retroviruses, 19(2), 103, 2003.

120. Marchetti, G., Meroni, L., Varchetta, S., Terzieva, V., Bandera, A., Manganaro, D., Molteni, C., Trabattoni, D., Fosssati, S., Clerici, M., Galli, M., Moroni, M., Franzetti, F., and Gori, A., Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment, J. Infect. Dis., 186(5), 606, 2002.

121. Lu, A.C., Jones, E.C., Chow, C., Miller, K.D., Herpin, B., Rock-Kres, D., Metcalf, J.A., Lane, H.C., and Kovacs, J.A., Increases in CD4⁺ T lymphocytes occur without increases in thymic size in HIV- infected subjects receiving interleukin-2 therapy, J. Acquir. Immune Defic. Syndr., 34(3), 299, 2003.

122. Uittenbogaart, C.H., Boscardin, W.J., Anisman-Posner, D.J., Koka, P.S., Bristol, G., and Zack, J.A., Effect of cytokines on HIV-induced depletion of thymocytes in vivo, AIDS, 14(10), 1317, 2000.

123. Napolitano, L.A., Lo, J.C., Gotway, M.B., Mulligan, K., Barbour, J.D., Schmidt, D., Grant, R.M., Halvorsen, R.A., Schambelan, M., and McCune, J.M., Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone, AIDS, 16(8), 1103, 2002.

124. Maggiolo, F., Taras, A., Pravettoni, M.G., Leone, M., Ingrosso, A., and Suter, F., Zidovudine and thymus humoral factor -2 in the treatment of HIV infection: preliminary clinical experience, Infection, 25(1), 35, 1997.

125. Carco, F. and Guazzotti, G., Therapeutic use of thymostimulin in HIV-seropositive subjects with lymphadenopathy syndrome, Recenti. Prog. Med., 84(11), 756, 1993.

126. Silvestris, F., Gernone, A., Frassanito, M.A., and Dammacco, F., Immunologic effects of long-term thympopentin treatment in patients with HIV-induced lymphadenopathy syndrome, J. Lab. Clin. Med., 113(2), 139, 1989.

127. Skotnicki, A.B., Zatz, M., Sztein, M.B., Goldstein, A.L., and Schulof, R.S., Effect of thymic hormones on interleukin 2 synthesis by lymphocytes from HIV-positive pre-AIDS subjects, Immunol. Invest., 17(2), 159, 1988.

128. Valesini, G., Barnaba, V., Benvenuto, R., Balsano, F., Mazzanti, P., and Cazzola, P., A calf thymus acid lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: second report, Eur. J. Cancer Clin. Oncol., 23(12), 1915, 1987.

129. Berner, Y., Handzel, Z.T., Pecht, M., Trainin, N., and Bentwich, Z., Attempted treatment of acquired immunodeficiency syndrome (AIDS) with thymic humoral factor, Isr. J. Med. Sci., 20(12), 1195, 1984.

130. Beall, G., Kruger, S., Morales, F., Imagawa, D., Goldsmith, J.A., Fisher, D., Steinberg, J., Phair, J., Whaling, S., and Bitran, J., A double-blind, placebo-controlled trial of thymostimulin in symptomatic HIV-infected patients, AIDS, 4(7), 679, 1990.

131. Dupuy, J.M., Gilmore, N., Goldman, H., Tsoukas, C., Pekovic, D., Chausseau, J.P., Duperval, R., Joly, M., Pelletier, L., and Thibaudeau, Y., Thymic epithelial cell transplantation in patients with acquired immunodeficiency syndrome. Evidence for infection by HIV-1 of newly differentiated T cells at the site of transplantation, Thymus, 17(4), 205, 1991.

132. Markert, M.L., Hicks, C.B., Bartlett, J.A., Harmon, J.L., Hale, L.P., Greenberg, M.L., Ferrari, G., Ottinger, J., Boeck, A., Kloster, A.L., McLaughlin, T.M., Bleich, K.B., Ungerleider, R.M., Lyerly, H.K., Wilkinson, W.E., Rousseau, F.S., Heath-Chiozzi, M.E., Leonard, L.M., Haase, A.T., Shaw, G.M., Bucy, R.P., Douek, D.C., Koup, R.A., Haynes, B.F., Bolognesi, D.P., and Weinhold, K.J., Effect of highly active antiretroviral therapy and thymic transplantation on immunoreconstitution in HIV infec­tion, AIDS Res. Hum. Retroviruses, 16(5), 403, 2000.